KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Exact Sciences (EXAS) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Exact Sciences (EXAS) over the last 17 years, with Q4 2025 value amounting to -$964.7 million.

  • Exact Sciences' Enterprise Value rose 706.29% to -$964.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$964.7 million, marking a year-over-year increase of 706.29%. This contributed to the annual value of -$964.7 million for FY2025, which is 706.29% up from last year.
  • Exact Sciences' Enterprise Value amounted to -$964.7 million in Q4 2025, which was up 706.29% from -$1.0 billion recorded in Q3 2025.
  • Exact Sciences' Enterprise Value's 5-year high stood at -$632.1 million during Q4 2022, with a 5-year trough of -$1.4 billion in Q1 2021.
  • Its 5-year average for Enterprise Value is -$901.9 million, with a median of -$837.7 million in 2022.
  • As far as peak fluctuations go, Exact Sciences' Enterprise Value surged by 4508.56% in 2022, and later tumbled by 3904.18% in 2024.
  • Over the past 5 years, Exact Sciences' Enterprise Value (Quarter) stood at -$1.0 billion in 2021, then soared by 38.66% to -$632.1 million in 2022, then fell by 23.03% to -$777.6 million in 2023, then tumbled by 33.48% to -$1.0 billion in 2024, then grew by 7.06% to -$964.7 million in 2025.
  • Its Enterprise Value stands at -$964.7 million for Q4 2025, versus -$1.0 billion for Q3 2025 and -$858.4 million for Q2 2025.